HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
PSNL
Personalis, Inc.
PSNL lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
PSNL Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
PSNL's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
PSNL PE Valuation
PSNL has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
PSNL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect PSNL's losses to shrink, with revenue growing.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
PSNL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.17 | -$0.29 |
| Q2 2026 | -$1.09 | +$0.19 |
| Q1 2026 | -$1.02 | +$0.27 |
| Q4 2025 | -$0.91 | +$0.46 |
| Q3 2025 | -$0.88 | +$0.80 |
| Q2 2025 | -$1.28 | +$0.36 |
| Q1 2025 | -$1.29 | +$0.61 |
| Q4 2024 | -$1.37 | +$0.88 |
PSNL has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over PSNL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over PSNL on profitability, with a higher operating margin.
PSNL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $25.6M | +77% |
| Q2 2026 | $22.4M | +30% |
| Q1 2026 | $15.5M | -25% |
| Q4 2025 | $17.3M | +3.2% |
| Q3 2025 | $14.5M | -44% |
| Q2 2025 | $17.2M | -24% |
| Q1 2025 | $20.6M | +5.5% |
| Q4 2024 | $16.8M | -15% |
PSNL's revenue is growing: $26M last quarter, up 77% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -139% | +22 points |
| Q2 2026 | -150% | -24 points |
| Q1 2026 | -208% | -122 points |
| Q4 2025 | -146% | -38 points |
| Q3 2025 | -161% | -105 points |
| Q2 2025 | -127% | -52 points |
| Q1 2025 | -86% | +11 points |
| Q4 2024 | -108% | +14 points |
PSNL's operating margin was −139% last quarter, up 22 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over PSNL on cash generation, producing positive trailing cash flow while its opponent burns cash.
PSNL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$30.1M | -$6.7M |
| Q2 2026 | -$29.6M | -$16.3M |
| Q1 2026 | -$25.7M | -$5.2M |
| Q4 2025 | -$22.3M | -$13.3M |
| Q3 2025 | -$23.4M | -$17M |
| Q2 2025 | -$13.2M | -$2.5M |
| Q1 2025 | -$20.5M | +$45K |
| Q4 2024 | -$9M | +$7.9M |
PSNL has burned cash in almost every quarter: −$108M over the past year, against −$66M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over PSNL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
PSNL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.7% | +1.8M shares |
| 1 year | +21% | +18.5M shares |
| 3 years | +125% | +59.5M shares |
| 5 years | +144% | +63.2M shares |
| Available history | +242% | +75.9M shares |
PSNL has 107M diluted shares, up 21% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
PSNL Net Leverage
PSNL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
PSNL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.9 | Neutral |
| Stochastic | 50.9 | Neutral |
PSNL's weekly RSI is 60 (neutral) and its Stochastic is 51 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
PSNL PE vs Healthcare Sector
PSNL has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
PSNL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $16.0 | 0.6% below |
| 20 week MA | $15.4 | 2.8% above |
| 50 week MA | $11.2 | 42% above |
| 100 week MA | $8.46 | 87% above |
| 200 week MA | $5.45 | 191% above |
PSNL has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
PSNL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.68 | $41.5 | +329% |
| 2021 | $41.5 | $14.4 | -65% |
| 2022 | $14.4 | $1.95 | -86% |
| 2023 | $1.95 | $2.10 | +7.7% |
| 2024 | $2.10 | $5.87 | +180% |
| 2025 | $5.87 | $8.14 | +39% |
| 2026 YTD | $8.14 | $15.9 | +95% |
PSNL has the edge over HIMS on returns for 2026, with the stronger performance.